Saqer Alkharabsheh is a Cardiology physician affiliated with Cleveland Clinic. OpenAlex indexes 29 publications with 366 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202510 payments
- Boston Scientific CorporationProgram year20251 payment
- Biosense Webster, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
56.4%Beta blocker27%Metoprolol Tartrate49%Metoprolol Succinate27%Carvedilol16%Sotalol9%Part D<11 patientsAntiarrhythmic14.2%Amiodarone Hcl60%Flecainide Acetate25%Dofetilide15%Part D<11 patients+ 5 more classes in this area
Blood & clotting
39%Factor Xa inhibitor29.9%Eliquis89%Xarelto11%Part D≥87 patientsP2Y12 inhibitor4.4%Clopidogrel100%Part D≥21 patients+ 2 more classes in this area
Metabolism & gastrointestinal
4.7%Proton pump inhibitor3.3%Pantoprazole Sodium100%Part D≥24 patientsPotassium supplement1.4%Klor-Con M20100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety evaluation of electrical cardioversion in the presence left ventricular thrombus
Journal of Stroke and Cerebrovascular Diseases
2025 - DIRECT ORAL ANTICOAGULANTS VS VITAMIN K ANTAGONISTS IN MANAGEMENT OF PATIENTS WITH LEFT VENTRICULAR THROMBUS: 10-YEAR EXPERIENCE
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Nissen, MD
Cleveland Clinic
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”